OSTEOARTHRITIS
Flavonoid supplement UP446 has significant symptomatic relief of knee osteoarthritis
This report has been verified
by one or more authors of the
original publication.
J Med Food. 2014 Jun;17(6):707-13
79 patients with mild-moderate knee osteoarthritis were included in this study. Patients were randomized to treatment with either UP446 500mg/day (S. baicalensis and A. catechu compound) or control naproxen sodium 440mg/day. The purpose was to investigate the effect of UP446 500mg/day on short-term outcome in comparison to an established conservative OA treatment. Over 1 week, pain and stiffness significantly reduced in patients treated with UP446. Further long-term placebo controlled assessments are required to determine the efficacy of this supplementation.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
